Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 May 7;321(17):1723-1725.
doi: 10.1001/jama.2019.2276.

Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016

Terrence Wong  1 , Katherine Dang  1 , Sanah Ladhani  1 , Ashwani K Singal  2 , Robert J Wong  1
Affiliations

Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016

Terrence Wong et al. JAMA. .

Abstract

This national survey study uses National Health and Nutrition Examination Survey (NHANES) data to estimate the prevalence of alcoholic fatty liver disease (AFLD) overall and with stage 2 or greater and stage 3 or greater fibrosis among US adults from 2001 to 2016.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr R. J. Wong reported serving on an advisory board for Gilead; serving on speakers bureaus for Gilead, Salix, and Bayer; and receiving research grants form Gilead and AbbVie. No other disclosures were reported.

Figures

Figure.
Figure.. Trends in Prevalence of Total Alcoholic Fatty Liver Disease (AFLD), AFLD With Stage 2 or Greater Fibrosis, and AFLD With Stage 3 or Greater Fibrosis Among US Adults From 2001-2002 to 2015-2016
Shaded areas adjacent to curves indicate 95% CIs. Data are based on 34 423 individuals in NHANES surveys.
See this image and copyright information in PMC

Comment in

References

    1. Singal AK, Bataller R, Ahn J, Kamath PS, Shah VH. ACG clinical guideline: alcoholic liver disease. Am J Gastroenterol. 2018;113(2):175-194. doi:10.1038/ajg.2017.469 - DOI - PMC - PubMed
    1. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol. 2013;59(1):160-168. doi:10.1016/j.jhep.2013.03.007 - DOI - PubMed
    1. Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817. doi:10.1136/bmj.k2817 - DOI - PMC - PubMed
    1. Aguilar M, Bhuket T, Torres S, Liu B, Wong RJ. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA. 2015;313(19):1973-1974. doi:10.1001/jama.2015.4260 - DOI - PubMed
    1. Unalp-Arida A, Ruhl CE. Liver fibrosis scores predict liver disease mortality in the United States population. Hepatology. 2017;66(1):84-95. doi:10.1002/hep.29113 - DOI - PMC - PubMed

Publication types